Developmental pharmacokinetics of propylene glycol in preterm and term neonates
Conclusion: A pharmacokinetic model was developed for PG co‐administered with paracetamol or phenobarbital in neonates. As such, large variability in PG exposure may be expected in neonates which are dependent on birth weight and postnatal age.© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society (Source: British Journal of Clinical Pharmacology)

Outcome In Chronic Stroke May Be Improved By Modifying Scar Tissue
New research from the Buck Institute for Research on Aging shows that modifying the scar tissue that develops following a stroke is a promising avenue for future treatments. The need for therapeutics for chronic stroke is compelling. There are 750,000 new strokes per year in the U.S., a leading cause of morbidity and mortality. Aside from physical and occupational therapy, treatments for the six million patients in the U.S. who suffer from chronic stroke are lacking; the vast majority of patients remain in an ongoing state of disability with little hope of return to normal function... (Source: Health News from Medical News Today)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div